000 | 02207 a2200673 4500 | ||
---|---|---|---|
005 | 20250517192751.0 | ||
264 | 0 | _c20180104 | |
008 | 201801s 0 0 eng d | ||
022 | _a1791-7530 | ||
024 | 7 |
_a10.21873/anticanres.12243 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPoprach, Alexandr | |
245 | 0 | 0 |
_aPazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients. _h[electronic resource] |
260 |
_bAnticancer research _c01 2018 |
||
300 |
_a449-456 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
650 | 0 | 4 | _aCzech Republic |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndazoles |
650 | 0 | 4 |
_aIndoles _xtherapeutic use |
650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-kit _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrimidines _xadverse effects |
650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, Platelet-Derived Growth Factor _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSulfonamides _xadverse effects |
650 | 0 | 4 | _aSunitinib |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aFiala, Ondrej | |
700 | 1 | _aChloupkova, Renata | |
700 | 1 | _aMelichar, Bohuslav | |
700 | 1 | _aLakomy, Radek | |
700 | 1 | _aPetrakova, Katarina | |
700 | 1 | _aZemanova, Milada | |
700 | 1 | _aKopeckova, Katerina | |
700 | 1 | _aSlaby, Ondrej | |
700 | 1 | _aStudentova, Hana | |
700 | 1 | _aKopecký, Jindrich | |
700 | 1 | _aKiss, Igor | |
700 | 1 | _aFinek, Jindrich | |
700 | 1 | _aDusek, Ladislav | |
700 | 1 | _aBuchler, Tomas | |
773 | 0 |
_tAnticancer research _gvol. 38 _gno. 1 _gp. 449-456 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.21873/anticanres.12243 _zAvailable from publisher's website |
999 |
_c27925153 _d27925153 |